The clinical value of multimodal neuroimaging in monoclonal antibody therapy for Alzheimer's disease - Quiz - MDSpire

The clinical value of multimodal neuroimaging in monoclonal antibody therapy for Alzheimer's disease

  • By

  • Yingte Wang

  • Hong Li

  • Jing Zhou

  • Saiyao Zhao

  • Airong Yang

  • Zhiming Li

  • May 8, 2026

  • 0 min

Share

Original Source(s)

The clinical value of multimodal neuroimaging in monoclonal antibody therapy for Alzheimer's disease

  • by Yingte Wang, Hong Li, Jing Zhou, Saiyao Zhao, Airong Yang, Zhiming Li

  • May 8, 2026

Related Content

Glial Fibrillary Acidic Protein and Neurofilament Light Reference Intervals in Healthy Individuals

Molecular signatures and biomarker development for limbic-predominant age-related TDP-43 encephalopathy (LATE)

Advancing Alzheimer Disease Prediction With Large Language Model–Based Linguistic Feature Analysis: Development and Validation Study